May Yoon Pwint

Ms. May Yoon Pwint

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2023 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
ECElisa Castagnola
Elisa Castagnola
ERElaine Marie Robbins
Elaine Marie Robbins
DKDaniela D. Krahe
Daniela D. Krahe
BWBingchen Wu
Bingchen Wu
MPMay Yoon Pwint
May Yoon Pwint
XCXinyan Cui
Xinyan Cui

8 May 2025 in Nature Reviews Methods Primers
Verified
Journal Article
Closed access
PDF file
NWNathaniel P. Williams
Nathaniel P. Williams
MVMihaly Voroslakos
Mihaly Voroslakos
DSDelin Shi
Delin Shi
MPMay Yoon Pwint
May Yoon Pwint
VLVittorino Lanzio
Vittorino Lanzio
XCXinyan Cui
Xinyan Cui

20 July 2022 in Biosensors
Verified
Journal Article
Open access
PDF file
ECElisa Castagnola
Elisa Castagnola
ERElaine Marie Robbins
Elaine Marie Robbins
BWBingchen Wu
Bingchen Wu
MPMay Yoon Pwint
May Yoon Pwint
RGRaghav Garg
Raghav Garg
XCXinyan Cui
Xinyan Cui
Dopamine (DA) plays a central role in the modulation of various physiological brain functions, including learning, motivation, reward, and movement control. The DA dynamic occurs over multiple timescales, including fast phasic release, as a result of neuronal firing and slow tonic release, which regulates the phasic firing. Real-time measurements of tonic and phasic DA concentrations in the living brain can shed light on the mechanism of DA dynamics underlying behavioral and psychiatric disorders and on the action of pharmacological treatments targeting DA. Current state-of-the-art in vivo DA detection technologies are limited in either spatial or temporal resolution, channel count, longitudinal stability, and ability to measure both phasic and tonic dynamics. We present here an implantable glassy carbon (GC) multielectrode array on a SU-8 flexible substrate for integrated multichannel phasic and tonic measurements of DA concentrations. The GC MEA demonstrated in vivo multichannel fast-scan cyclic voltammetry (FSCV) detection of electrically stimulated phasic DA release simultaneously at different locations of the mouse dorsal striatum. Tonic DA measurement was enabled by coating GC electrodes with poly(3,4-ethylenedioxythiophene)/carbon nanotube (PEDOT/CNT) and using optimized square-wave voltammetry (SWV). Implanted PEDOT/CNT-coated MEAs achieved stable detection of tonic DA concentrations for up to 3 weeks in the mouse dorsal striatum. This is the first demonstration of implantable flexible MEA capable of multisite electrochemical sensing of both tonic and phasic DA dynamics in vivo with chronic stability.

9 October 2024 in Advanced Materials Technologies
Verified
Journal Article
Open access
ECElisa Castagnola
Elisa Castagnola
QCQun Cao
Qun Cao
ERElaine Marie Robbins
Elaine Marie Robbins
BWBingchen Wu
Bingchen Wu
MPMay Yoon Pwint
May Yoon Pwint
XCXinyan Cui
Xinyan Cui
Real‐time measurement of neurochemical and electrophysiological activities in the living brain is vital for advancing neuroscience and understanding brain disorders. Carbon fiber microelectrodes (CFEs) have been widely utilized for in vivo electrochemical detection due to their subcellular size, biocompatibility, and desirable electrochemical properties, and CFE arrays have demonstrated excellent multi‐site chronic sensing of dopamine (DA) and neural activity recording capabilities. However, manual fabrication of CFE arrays lacks reproducibility and batch production capacity. Alternatively, photolithography enables batch fabrication of glassy carbon (GC) multielectrode arrays (GC‐MEAs) with high resolution and reproducibility, but the insertion of planar flexible MEAs poses challenges. In this study, GC fiber‐like (GCF) MEAs are presented and fabricated using photolithography. The GCF MEAs feature fiber‐like GC electrodes with small cross‐sections, facilitating self‐insertion into brain tissue without additional aids. Batch fabrication of GCF MEAs allows for customizable designs with minimal manual intervention. Comparative analysis with CFEs demonstrates improved electrochemical properties of GCF. In vivo experiments in mouse brains confirm the GCF MEAs' ability to measure neurotransmitter concentrations and record neural activities. This novel fabrication approach is promising for multimodal electrical and chemical measurements with minimal footprint, offering significant advancements in neural interface technology for neuroscience research and clinical applications.

15 February 2024 in Micromachines
Verified
Journal Article
Open access
PDF file
EFEmma-Bernadette Faul
Emma-Bernadette Faul
ABAustin Broussard
Austin Broussard
DRDaniel R. Rivera
Daniel R. Rivera
MPMay Yoon Pwint
May Yoon Pwint
BWBingchen Wu
Bingchen Wu
ECElisa Castagnola
Elisa Castagnola
Flexible multielectrode arrays with glassy carbon (GC) electrodes and metal interconnection (hybrid MEAs) have shown promising performance in multi-channel neurochemical sensing. A primary challenge faced by hybrid MEAs fabrication is the adhesion of the metal traces with the GC electrodes, as prolonged electrical and mechanical stimulation can lead to adhesion failure. Previous devices with GC electrodes and interconnects made of a homogeneous material (all GC) demonstrated exceptional electrochemical stability but required miniaturization for enhanced tissue integration and chronic electrochemical sensing. In this study, we used two different methods for the fabrication of all GC-MEAs on thin flexible substrates with miniaturized features. The first method, like that previously reported, involves a double pattern-transfer photolithographic process, including transfer-bonding on temporary polymeric support. The second method requires a double-etching process, which uses a 2 µm-thick low stress silicon nitride coating of the Si wafer as the bottom insulator layer for the MEAs, bypassing the pattern-transfer and demonstrating a novel technique with potential advantages. We confirmed the feasibility of the two fabrication processes by verifying the practical conductivity of 3 µm-wide 2 µm-thick GC traces, the GC microelectrode functionality, and their sensing capability for the detection of serotonin using fast scan cyclic voltammetry. Through the exchange and discussion of insights regarding the strengths and limitations of these microfabrication methods, our goal is to propel the advancement of GC-based MEAs for the next generation of neural interface devices.

11 April 2024 in Advanced Healthcare Materials
Verified
Journal Article
Open access
PDF file
QYQIANRU YANG
QIANRU YANG
BWBingchen Wu
Bingchen Wu
ECElisa Castagnola
Elisa Castagnola
MPMay Yoon Pwint
May Yoon Pwint
NWNathaniel P. Williams
Nathaniel P. Williams
XCXinyan Cui
Xinyan Cui
Cerebral neural electronics play a crucial role in neuroscience research with increasing translational applications such as brain–computer interfaces for sensory input and motor output restoration. While widely utilized for decades, the understanding of the cellular mechanisms underlying this technology remains limited. Although two‐photon microscopy (TPM) has shown great promise in imaging superficial neural electrodes, its application to deep‐penetrating electrodes is technically difficult. Here, a novel device integrating transparent microelectrode arrays with glass microprisms, enabling electrophysiology recording and stimulation alongside TPM imaging across all cortical layers in a vertical plane, is introduced. Tested in Thy1‐GCaMP6 mice for over 4 months, the integrated device demonstrates the capability for multisite electrophysiological recording/stimulation and simultaneous TPM calcium imaging. As a proof of concept, the impact of microstimulation amplitude, frequency, and depth on neural activation patterns is investigated using the setup. With future improvements in material stability and single unit yield, this multimodal tool greatly expands integrated electrophysiology and optical imaging from the superficial brain to the entire cortical column, opening new avenues for neuroscience research and neurotechnology development.